Anthropic 以四億美元併購 AI 生技新創 Coefficient Bio
Anthropic is acquiring biotech startup Coefficient Bio for $400 million, a company focused on using artificial intelligence to optimize new drug discovery. Coefficient Bio’s team is made up of industry-experienced experts who improve drug R&D efficiency to shorten the time from experiments to clinical applications. Anthropic’s acquisition goal is to strengthen its technical footprint in the healthcare and life sciences sectors, despite regulatory challenges in the U.S. market.
ChainNewsAbmedia·04-14 14:45
